Home › Immunoblastic Lymphadenopathy › Missouri › St. Louis
Immunoblastic Lymphadenopathy clinical trials in St. Louis, MO
3 studies for Immunoblastic Lymphadenopathy are looking for participants at sites in and around St. Louis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
RecruitingPhase 2
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- and 2 more
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
RecruitingPhase 3
- Washington University in St. Louis, St Louis
A Registry for People With T-cell Lymphoma
RecruitingObservational study
- Washington University (Data Collection Only), St Louis
Immunoblastic Lymphadenopathy trials in other cities
- New York City, NY5 studies
- Chicago, IL4 studies
- Houston, TX4 studies
- Miami, FL4 studies
- Durham, NC4 studies
- Baldwin Park, CA3 studies
- Ann Arbor, MI3 studies
- Boston, MA3 studies
- New Haven, CT3 studies
- Atlanta, GA3 studies
- Columbus, OH3 studies
- Edison, NJ3 studies
Other studies in St. Louis
- Non-Small Cell Lung Cancer73 studies
- Breast Cancer64 studies
- Metastatic Cancer54 studies
- Colorectal Cancer50 studies
- Prostate Cancer46 studies
- Cancer (all types)46 studies
- Lung Cancer39 studies
- Ovarian Cancer38 studies
- Pancreatic Cancer33 studies
- Endometrial Cancer29 studies
- Head and Neck Squamous Cell Carcinoma28 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.